The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Nonalcoholic Fatty Liver Disease
Open accessAbstract
Abstract/Summary NAFLD is an important cause of morbidity and mortality worldwide both because of cardiovascular, hepatic and oncologic sequelae as well as because it is rapidly becoming the leading cause of end stage liver disease and liver transplant. With a prevalence of 30% in the US, it has reached epidemic proportions. While the metabolic syndrome is a common risk factor, there are differences among racial and ethnic groups, suggesting the complex interaction between hormonal, nutritional and genetic factors at play in disease pathogenesis. The clinical syndrome of NAFLD spans from bland steatosis to steatohepatitis which can progress to fibrosis and cirrhosis. The pathogenesis including roles of hormones, nutritional and intestinal dysbiosis, insulin resistance, lipotoxicity, and hepatic inflammation, and genes are examined. Non-invasive testing and liver biopsy indications are reviewed. Approved and investigational therapies for NAFLD and NASH are outlined in this review of a disease that is currently an area of great interest to the hepatology community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Armstrong, M. J., Gaunt, P., Aithal, G. P., Barton, D., Hull, D., Parker, R., Hazlehurst, J. M., Guo, K., Abouda, G., Aldersley, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00803-x · Cited by 2,203
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
Castéra, L., Foucher, J., Bernard, P.-H., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2010) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,159
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Sookoian, S., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 920
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.048 · Cited by 812
Jenkins, C. M., Mancuso, D. J., Yan, W., Sims, H. F., Gibson, B., & Gross, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407841200 · Cited by 779
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Lassailly, G., Caiazzo, R., Buob, D., Pigeyre, M., Verkindt, H., Labreuche, J., Raverdy, V., Leteurtre, E., Dharancy, S., Louvet, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.014 · Cited by 762
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Intestinal microbiota in patients with nonalcoholic fatty liver disease
Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749
Teff, K. L., Elliott, S. S., Tschöp, M., Kieffer, T. J., Rader, D., Heiman, M., Townsend, R. R., Keim, N. L., D’Alessio, D., & Havel, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031855 · Cited by 742
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes
Fu, Z., R. Gilbert, E., & Liu, D. (2013) · Current Diabetes Reviews · doi:10.2174/157339913804143225 · Cited by 732
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Fracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 711
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Images of desire: food-craving activation during fMRI
Pelchat, M. L., Johnson, A., Chan, R., Valdez, J., & Ragland, J. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.08.023 · Cited by 667
What if Minkowski Had Been Ageusic? An Alternative Angle on Diabetes
McGarry, J. D. (1992) · Science · doi:10.1126/science.1439783 · Cited by 657
He, S., McPhaul, C., Li, J. Z., Garuti, R., Kinch, L., Grishin, N. V., Cohen, J. C., & Hobbs, H. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064501 · Cited by 610
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu, Z., Gilbert, E. R., & Liu, D. (2013) · PubMed · Cited by 600
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Gut microbiota and metabolic syndrome
Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534
Opioid modulation of taste hedonics within the ventral striatum
Kelley, A. E., Bakshi, V. P., Haber, S. N., Steininger, T. L., Will, M. J., & Zhang, M. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00751-5 · Cited by 526
Myers, R. P., Pomier–Layrargues, G., Kirsch, R., Pollett, A., Duarte–Rojo, A., Wong, D., Beaton, M., Levstik, M., Crotty, P., & Elkashab, M. (2012) · Hepatology · doi:10.1002/hep.24624 · Cited by 503
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403
Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379
Page, K. A., Chan, O., Arora, J., Belfort-DeAguiar, R., Dzuira, J., Roehmholdt, B., Cline, G. W., Naik, S., Sinha, R., Constable, R. T., et al. (2013) · JAMA · doi:10.1001/jama.2012.116975 · Cited by 379
Lee, S. S., Park, S. H., Kim, H. J., Kim, S. Y., Kim, M.-Y., Kim, D. Y., Suh, D. J., Kim, K. M., Bae, M. H., Lee, J. Y., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.008 · Cited by 372
Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362
Chitturi, S., Farrell, G., Frost, L., Kriketos, A., Lin, R., Liddle, C., Samarasinghe, D., & George, J. (2002) · Hepatology · doi:10.1053/jhep.2002.34738 · Cited by 362
Verma, S., Jensen, D., Hart, J., & Mohanty, S. R. (2013) · Liver International · doi:10.1111/liv.12226 · Cited by 314
Gender and racial differences in nonalcoholic fatty liver disease
Pan, J.-J. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i5.274 · Cited by 297
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Abid, A., Taha, O., Nseir, W., Farah, R., Grosovski, M., & Assy, N. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.033 · Cited by 287
Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
Gao, B., & Tsukamoto, H. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.025 · Cited by 287
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
Li, J. Z., Huang, Y., Karaman, R., Ivanova, P. T., Brown, H. A., Roddy, T., Castro-Perez, J., Cohen, J. C., & Hobbs, H. H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65179 · Cited by 283
Straub, B. K., Stoeffel, P., Heid, H., Zimbelmann, R., & Schirmacher, P. (2008) · Hepatology · doi:10.1002/hep.22268 · Cited by 256
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed · doi:10.3748/wjg.v17.i23.2801 · Cited by 242
Basantani, M. K., Sitnick, M. T., Cai, L., Brenner, D. S., Gardner, N. P., Li, J. Z., Schoiswohl, G., Yang, K., Kumari, M., Gross, R. W., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011205 · Cited by 242
Santoro, N., Kursawe, R., D'Adamo, E., Dykas, D. J., Zhang, C. K., Bale, A. E., Calí, A. M., Narayan, D., Shaw, M. M., Pierpont, B., et al. (2010) · Hepatology · doi:10.1002/hep.23832 · Cited by 218
Adams, L. A., Lindor, K. D., & Angulo, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30444.x · Cited by 207
Giorgio, V., Miele, L., Principessa, L., Ferretti, F., Villa, M. P., Negro, V., Grieco, A., Alisi, A., & Nobili, V. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.02.010 · Cited by 187
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 180
Pathophysiology of lipid droplet proteins in liver diseases
Carr, R. M., & Ahima, R. S. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.021 · Cited by 179
Self-citationTargher, G., Bertolini, L., Rodella, S., Zoppini, G., Scala, L., Zenari, L., & Falezza, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02527.x · Cited by 172
Chalasani, N. P., Sanyal, A. J., Kowdley, K. V., Robuck, P. R., Hoofnagle, J., Kleiner, D. E., Ünalp, A., & Tonascia, J. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2008.09.003 · Cited by 168
Adiponectin, a key adipokine in obesity related liver diseases
Christa, Buechler, Josef, Wanninger, Markus, M. L., & Neumeier (2011) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 167
Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status
Booth, S. L., Golly, I., Sacheck, J. M., Roubenoff, R., Dallal, G. E., Hamada, K., & Blumberg, J. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.143 · Cited by 160
Endoscopic bariatric therapies
Abu Dayyeh, B. K., Edmundowicz, S. A., Jonnalagadda, S., Kumar, N., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.02.023 · Cited by 160
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 156
Palmer, N. D., Musani, S. K., Yerges‐Armstrong, L. M., Feitosa, M. F., Bielak, L. F., Hernáez, R., Kahali, B., Carr, J. J., Harris, T. B., Jhun, M. A., et al. (2013) · Hepatology · doi:10.1002/hep.26440 · Cited by 150
Hernáez, R., McLean, J., Lazo, M., Brancati, F. L., Hirschhorn, J. N., Borecki, I. B., Harris, T. B., Nguyen, T. T., Kamel, I. R., Bonekamp, S., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.011 · Cited by 149
Non-Organ-Specific Autoantibodies in Nonalcoholic Fatty Liver Disease: Prevalence and Correlates
Loria, P., Lonardo, A., Leonardi, F., Fontana, C., Carulli, L., Verrone, A. M., Borsatti, A., Bertolotti, M., Cassani, F., Bagni, A., et al. (2003) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000004522.36120.08 · Cited by 142
Straub, B. K., Gyoengyoesi, B., Koenig, M., Hashani, M., Pawella, L., Herpel, E., Mueller, W. C., Macher‐Goeppinger, S., Heid, H., & Schirmacher, P. (2012) · Histopathology · doi:10.1111/his.12038 · Cited by 138
NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis
Fleischman, M. W., Budoff, M., Zeb, I., Li, D., & Foster, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i17.4987 · Cited by 134
FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease
Carr, R. M., & Reid, A. E. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0500-2 · Cited by 132
Self-citationKallwitz, E. R., Daviglus, M. L., Allison, M., Emory, K., Zhao, L., Kuniholm, M. H., Chen, J., Gouskova, N., Pirzada, A., Talavera, G. A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.037 · Cited by 129
Prevalence and Significance of Autoantibodies in Patients With Non-Alcoholic Steatohepatitis
Cotler, S. J., Kanji, K., Keshavarzian, A., Jensen, D. M., & Jakate, S. M. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139072.38580.a0 · Cited by 122
Nonalcoholic Fatty Liver Disease in Latinos
Saab, S., Manne, V., Nieto, J. M., Schwimmer, J. B., & Chalasani, N. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.05.001 · Cited by 117
Gorden, A., Yang, R., Yerges‐Armstrong, L. M., Ryan, K. A., Speliotes, E. K., Borecki, I. B., Harris, T. B., Chu, X., Wood, G. C., Still, C. D., et al. (2013) · Human Heredity · doi:10.1159/000346195 · Cited by 97
Implications of diet on nonalcoholic fatty liver disease
Sullivan, S. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283358a58 · Cited by 83
Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice
Carr, R. M., Patel, R. T., Rao, V., Dhir, R. N., Graham, M. J., Crooke, R. M., & Ahima, R. S. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00177.2011 · Cited by 83
Self-citationEthnic-Specific Criteria for the Metabolic Syndrome
Liu, J., Grundy, S. M., Wang, W., Smith, S. C., Vega, G. L., Wu, Z., Zeng, Z., Wang, W., & Zhao, D. H. (2006) · Diabetes Care · doi:10.2337/dc06-0481 · Cited by 82
Sookoian, S. C., & Pirola, C. J. (2016) · Scientific Reports · doi:10.1038/srep27718 · Cited by 26
Lai, H., Lin, W., Chen, P., et al. (2005) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607105029006401 · Cited by 14
Cited by
Vujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205
Self-citationFang, L., Li, J., Zeng, H., & Liu, J. (2024) · Primary Care Diabetes · doi:10.1016/j.pcd.2024.03.005 · Cited by 34
Fateh, H. L., Rashid, S. A., Muhammad, S. S., Al-Jaf, S. H., & Ali, A. M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1181706 · Cited by 13
Metadata
- Authors
- Carr, R. M., Oranu, A., & Khungar, V.
- Venue
- Gastroenterology Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 45
- Issue
- 4
- Pages
- 639-652
- ISSN
- 0889-8553 (ISSN-L)
- OpenAlex
- W2556576707
- Cited by
- 280
- References
- 87
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.